APOLLO HOSPITALS ENTER. L vs FREDUN PHARMACEUTICALS L

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and FREDUN PHARMACEUTICALS L (FREDUN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs FREDUN on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability31
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

APOLLOHOSP takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

64.06
P/E ratio
100.89
12.55
P/B ratio
9.15
0.23%
Dividend yield
0.05%
₹135.04
EPS
₹14.65

Profitability

APOLLOHOSP takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
14.80%
18.00%
Return on capital
19.00%
15.00%
EBITDA margin
12.00%
7.94%
Net margin
4.63%

Growth

FREDUN takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
32.46%
33.39%
Profit CAGR (3Y)
43.64%

Size & financial health

APOLLOHOSP takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.24L Cr
Market cap
₹398 Cr
₹25,228 Cr
Revenue
₹454 Cr
₹2,003 Cr
Net profit
₹21 Cr
0.32
Debt / equity
0.80
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
FREDUN PHARMACEUTICALS L
  • + ["Company is expected to give good quarter", "Company has delivered good profit growth of 75.2% CAGR over last 5 years", "Debtor days have improved from 87.9 to 53.2 days.", "Company's median sales growth is 28.6% of last 10 years"]
  • ["Stock is trading at 8.69 times its book value", "Promoter holding has decreased over last 3 years: -5.05%"]
APOLLO HOSPITALS ENTER. L full analysis FREDUN PHARMACEUTICALS L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLOHOSP vs FREDUN: Share Price, Valuation & Which to Buy | DocStoX